Altered Methylprednisolone Pharmacodynamics in Healthy Subjects WithHistamine N-MethyltransferaseC314T Genetic Polymorphism

Journal of Clinical Pharmacology - United States
doi 10.1177/0091270006286434
Full Text
Abstract

Available in full text

Categories
Pharmacology
Date
Authors
Publisher

Wiley-Blackwell

Related search

Effect of Fluconazole Coadministration and CYP2C9 Genetic Polymorphism on Siponimod Pharmacokinetics in Healthy Subjects

Clinical Pharmacokinetics
Pharmacology
2018English

Gender-Based Effects on Methylprednisolone Pharmacokinetics and Pharmacodynamics

Clinical Pharmacology and Therapeutics
Pharmacology
1993English

Effect of Voriconazole on the Pharmacokinetics and Pharmacodynamics of Zolpidem in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2007English

Pharmacokinetics, Pharmacodynamics, and Safety of Peficitinib (ASP015K) in Healthy Male Caucasian and Japanese Subjects

Clinical Drug Investigation
MedicinePharmacology
2020English

Platelet Count and Interleukin 6 Gene Polymorphism in Healthy Subjects

BMC Medical Genetics
Genetics
2001English

Pharmacokinetics, Pharmacodynamics, Tolerability and Safety of Single Doses of Bivalirudin in Healthy Chinese Subjects

Biological and Pharmaceutical Bulletin
MedicinePharmacologyPharmaceutical Science
2011English

Effect of MDR1 C3435T Polymorphism on Lansoprazole in Healthy Japanese Subjects

European Journal of Clinical Pharmacology
MedicinePharmacology
2009English

Steady-State Pharmacokinetics and Pharmacodynamics of CHF3381, a Novel Antineuropathic Pain Agent, in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2005English

Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of the Anti-Cd38 Cytolytic Antibody TAK-079 in Healthy Subjects

British Journal of Clinical Pharmacology
Pharmacology
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy